BHVN
Biohaven Ltd.
12.90$
-2.1%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 81.1% | 86.2% | 83.3% | 87.8% | 86.3% | 87.5% | 83.4% | 86.3% | 79.1% | 81.6% | 82.7% | 80.0% | |
| 29.2% | 48.4% | 43.7% | 41.0% | 16.5% | 16.1% | 21.4% | 30.1% | 45.2% | 50.9% | 58.5% | 64.2% | |
| 62.9% | 74.4% | 67.7% | 75.0% | 74.2% | 79.0% | 70.3% | 73.6% | 63.6% | 70.7% | 74.6% | 72.3% | |
| 3.9% | 2.6% | 2.0% | 1.3% | 1.0% | 0.4% | – | – | – | – | – | – | |
| 8.9% | – | – | – | -1.0% | – | – | – | – | – | – | – | |
| 13.0% | – | – | – | – | – | – | – | – | – | – | – | |
| 0.4% | 0.3% | 0.3% | 0.2% | 0.3% | 0.2% | 0.3% | 0.3% | 0.3% | 0.3% | 0.3% | 0.4% | |
| 4.8% | 3.6% | 4.4% | 3.2% | 3.6% | 3.0% | 4.0% | 3.3% | 4.5% | 4.1% | 3.9% | 5.0% | |
| 24.2% | 16.6% | 28.0% | 34.1% | 38.1% | 31.2% | 43.5% | 75.5% | 104.2% | 88.5% | 72.2% | 96.7% | |
| 16.2% | 10.8% | 20.7% | 26.8% | 29.8% | 25.1% | 35.7% | 22.6% | 27.6% | 25.7% | 11.2% | 16.9% | |
| 0.9% | 0.6% | 0.8% | 0.6% | 0.7% | 0.6% | 1.0% | 0.9% | 1.3% | 1.3% | 1.3% | 1.3% | |
| 2.5% | 3.0% | 8.7% | 3.0% | 3.9% | 2.9% | 4.2% | 3.6% | 4.3% | 2.6% | 2.2% | 3.3% | |
| – | – | – | – | – | – | – | 46.7% | 65.6% | 52.9% | 51.9% | 70.0% | |
| 75.8% | 83.4% | 72.0% | 65.9% | 61.9% | 68.8% | 56.5% | 24.5% | -4.2% | 11.5% | 27.8% | 3.3% | |
| -92.6% | -97.3% | -162.2% | -171.4% | -227.0% | -218.8% | -341.5% | -320.8% | -473.9% | -461.7% | -474.9% | -634.5% | |
| 17.9% | 15.6% | 19.5% | 15.1% | 18.5% | 16.4% | 22.2% | 18.6% | 25.9% | 26.6% | 31.6% | 40.6% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.